Walleye Capital’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-315
Closed -$2.22K 4701
2025
Q4
$2.22K Sell
315
-152,046
-100% -$917K ﹤0.01% 4371
2025
Q3
$838K Buy
152,361
+108,249
+245% +$530K ﹤0.01% 2229
2025
Q2
$228K Buy
+44,112
New +$264K ﹤0.01% 3260
2025
Q1
Sell
-469
Closed -$3.56K 4715
2024
Q4
$3.46K Buy
+469
New +$3.37K ﹤0.01% 4634
2024
Q3
Sell
-67,363
Closed -$331K 5610
2024
Q2
$331K Buy
+67,363
New +$406K ﹤0.01% 3892
2024
Q1
Sell
-27,014
Closed -$212K 5660
2023
Q4
$212K Buy
+27,014
New +$174K ﹤0.01% 3636
2021
Q3
Sell
-30,000
Closed -$836 1714
2021
Q2
$836 Buy
+30,000
New +$792K 0.03% 527

Other funds holding LFST

Walleye Capital's LFST Position: Q1 2026 in Review

Walleye Capital sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 315 shares — an estimated $2.22K sold.

Walleye Capital first reported a position in LFST in Q2 2021 and held it in 7 quarters. The position peaked at $838K in Q3 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Walleye Capital reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 315 Lifestance Health shares in Q1 2026, an estimated $2.22K.
  • Walleye Capital first reported a position in Lifestance Health in Q2 2021 and held it in 7 quarters.
  • Walleye Capital's Lifestance Health position peaked at $838K in Q3 2025.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.